Valdés-Rodríguez R, Torres-Álvarez B, González-Muro J, Almeda-Valdés P

Idioma: Español
Referencias bibliográficas: 89
Paginas: 162-168
Archivo PDF: 90.01 Kb.

RESUMEN

La piel es un órgano estrechamente relacionado con el sistema endocrino. El sistema endocrino participa en el desarrollo y funcionamiento normal de la piel. La mayoría de las hormonas tienen efectos en la piel, la unidad pilosebácea, las glándulas sudoríparas ecrinas y apocrinas a través de receptores localizados en estos órganos. Por otra parte, en la piel ocurre la síntesis de diferentes hormonas, por lo que también se puede considerar como un órgano endocrino. En este artículo se presenta una revisión de los efectos de algunas hormonas en la piel.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Makrantonaki E, Zouboulis CC. Dermatoendocrinology. Skin aging. Hautarzt. 2010;61:505-10.

2. Zouboulis CC. Human skin: an independent peripheral endocrine organ. Horm Res. 2000;54:230-42.

3. Zouboulis CC. The skin as an endocrine organ. Dermatoendocrinol. 2009;1:250-2.

4. Navarrete G. Histología de la piel. Rev Fac Med UNAM. 2003;46:130-3.

5. Yamaguchi Y, Hearing VJ. Physiological factors that regulate skin pigmentation. Biofactors. 2009;35:193-9.

6. Baxter LL, Loftus SK, Pavan WJ. Networks and pathways in pigmentation, health, and disease. Wiley Interdiscip Rev Syst Biol Med. 2009;1:359-71.

7. Boulais N, Misery L. The epidermis: a sensory tissue. Eur J Dermatol. 2008;18:119-27.

8. Kanitakis J. Anatomy, histology and immunohistochemistry of normal human skin. Eur J Dermatol. 2002;12:390-9.

9. Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000;21:363-92.

10. Deplewski D, Rosenfield RL. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology. 1999;140:4089-94.

11. Lee SW, Kim SH, Kim JY, Lee Y. The effect of growth hormone on fibroblast proliferation and keratinocyte migration. J Plast Reconstr Aesthet Surg. 2010;63:e364-9.

12. Dioufa N, Schally AV, Chatzistamou I, et al. Acceleration of wound healing by growth hormone-releasing hormone and its agonists. Proc Natl Acad Sci U S A. 2010;107:18611-5.

13. Jørgensen PH, Oxlund H. Growth hormone increases the biomechanical strength and collagen deposition rate during the early phase of skin wound healing. Wound Repair Regen. 1996;4:40-7.

14. Makrantonaki E, Schönknecht P, Hossini AM, et al. Skin and brain age together: The role of hormones in the ageing process. Exp Gerontol. 2010;45:801-13.

15. Laron Z. Effects of growth hormone and insulin-like growth factor 1 deficiency on ageing and longevity. Novartis Found Symp. 2002;242:125-37.

16. Goffin V, Bernichtein S, Touraine P, Kelly PA. Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev. 2005;26:400-22.

17. Richards RG, Hartman SM. Human dermal fibroblast cells express prolactin. J Invest Dermatol. 1996;106:1250-5.

18. Poumay Y, Jolivet G, Pittelkow MR, et al. Human epidermal keratinocytes upregulate expression of the prolactin receptor after the onset of terminal differentiation, but do not respond to prolactin. Arch Biochem Biophys. 1999;364:247-53.

19. Robertson MT, Alho HR, Martin AA. Localization of prolactin-like immunoreactivity in grafted human sweat glands. J Histochem Cytochem. 1989;37:625-8.

20. Foitzik K, Krause K, Conrad F, Nakamura M, Funk W, Paus R. Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol. 2006;168:748-56.

21. Foitzik K, Langan EA, Paus R. Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone. J Invest Dermatol. 2009;129:1071-87.

22. Zouboulis CC. The sebaceous gland. Hautarzt. 2010;61:467-8.

23. Zouboulis CC. Frontiers in sebaceous gland biology and pathology. Exp Dermatol. 2008;17:542-51.

24. Gáspár E, Hardenbicker C, Bodó E, et al. Thyrotropin releasing hormone (TRH): a new player in human hair-growth control. FASEB J. 2010;24:393-403.

25. Neumann S. Constitutively active thyrotropin and thyrotropin-releasing hormone receptors and their inverse agonists. Methods Enzymol. 2010;485:147-60.

26. Bodó E. Thyroid-stimulating hormone, a novel, locally produced modulator of human epidermal functions, is regulated by thyrotropin-releasing hormone and thyroid hormones. Endocrinology. 2010;151:1633-42.

27. Sugrue ML. The thyrotropin-releasing hormone gene is regulated by thyroid hormone at the level of transcription in vivo. Endocrinology. 2010;151:793-801.

28. Paus R. A neuroendocrinological perspective on human hair follicle pigmentation. Pigment Cell Melanoma Res. 2011;24:89-106.

29. Langan EA, Ramot Y, Hanning A, et al. Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. Br J Dermatol. 2010;162:1127-31.

30. Galas L, Raoult E, Tonon MC, et al. TRH acts as a multifunctional hypophysiotropic factor in vertebrates. Gen Comp Endocrinol. 2009;164:40-50.

31. Cianfarani F, Baldini E, Cavalli A, et al. TSH receptor and thyroid specific gene expression in human skin. J Invest Dermatol. 2010;130:93-101.

32. Bodó E, Kromminga A, Bíró T, et al. Human female hair follicles are a direct, nonclassical target for thyroid-stimulating hormone. J Invest Dermatol. 2009;129:1126-39.

33. Tiede S, Bohm K, Meier N, Funk W, Paus R. Endocrine controls of primary adult human stem cell biology: thyroid hormones stimulate keratin 15 expression, apoptosis, and differentiation in human hair follicle epithelial stem cells in situ and in vitro. Eur J Cell Biol. 2010;89:769-77.

34. Ramot Y, Paus R, Tiede S, Zlotogorski A. Endocrine controls of keratin expression. Bioessays. 2009;31:389-99.

35. Van Beek N, Bodó E, Kromminga A, et al. Thyroid hormones directly alter human hair follicle functions: anagen prolongation and stimulation of both hair matrix keratinocyte proliferation and hair pigmentation. J Clin Endocrinol Metab. 2008;93:4381-8.

36. Hall PF. The influence of hormones on melanogenesis. Australas J Dermatol. 1969;10:125-39.

37. Hennings H, Michael D, Cheng C, Steinert P, Holbrook K, Yuspa SH. Calcium regulation of growth and differentiation in mouse epidermal cells in culture. Cell. 1980;9:245-54.

38. Hunt TK, Hopf H, Hussain Z. Physiology of wound healing. Adv Skin Wound Care. 2000;13:6-11.

39. Lansdown AB. Calcium: a potential central regulator in wound healing in the skin. Wound Repair Regen. 2002;10:271-85.

40. Blomme EA. Sugimoto Y, Lin YC, Capen CC, Rosol TJ. Parathyroid hormone-related protein is a positive regulator of keratinocyte growth factor expression by normal dermal fibroblasts. Mol Cell Endocrinol. 1999;152:189-97.

41. Lehmann B, Querings K, Reichrath J. Vitamin D and skin: new aspects for dermatology. Exp Dermatol. 2004;13:11-5.

42. Henry HL. Vitamin D hydroxylases. J Cell Biochem. 1992;49:4-9.

43. Krämer C, Seltmann H, Seifert M, Tilgen W, Zouboulis CC, Reichrath J. Characterization of the vitamin D endocrine system in human sebocytes in vitro. J Steroid Biochem Mol Biol. 2009;113:9-16.

44. Reichrath J. Vitamin D and the skin: an ancient friend, revisited. Exp Dermatol. 2007;16:618-25.

45. Reichrath J, Lehmann B, Carlberg C, Varani J, Zouboulis CC. Vitamins as hormones. Horm Metab Res. 2007;39:71-84.

46. De Haes P, Garmyn M, Degreef H, Vantieghem K, Bouillon R, Segaert S. 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J Cell Biochem. 2003;89:663-73.

47. Aguilera G. Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol Metab. 1998;9:329-36.

48. Nagahama M, Funasaka Y, Fernández-Frez ML, et al. Immunoreactivity of alpha-melanocyte-stimulating hormone, adrenocorticotrophic hormone and beta-endorphin in cutaneous malignant melanoma and benign melanocytic naevi. Br J Dermatol. 1998;138:981-5.

49. Slominski A, Ermak G, Mazurkiewicz JE, Baker J, Wortsman J. Characterization of corticotrophin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab. 1998;83:1020-4.

50. Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev. 2000;80:979-1020.

51. Wakamatsu K, Graham A, Cook D, Thody JD. Characterisation of ACTH peptides in human skin and their activation of melanocortin-1 receptor. Pigment Cell Res. 1997;10:288-97.

52. Slominski A, Wortsman J, Mazurkiewicz JE, et al. Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med. 1993;122:658-66.

53. Slominski A, Paus R, Wortsman J. On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol. 1993;93:C1-6.

54. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ. Variants of melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nature Genet. 1995;11:328-30.

55. Zhang L, Anthonavage M, Huang Q, Li W, Eisinger M. Proopiomelanocortin peptides and sebogenesis. Ann NY Acad Sci. 2003;994:154-61.

56. Thody AJ, Shuster S. Control and function of sebaceous glands. Physiol Rev. 1989;69:383-416.

57. Zouboulis CC, Böhm M. Neuroendocrine regulation of sebocytes – a pathogenetic link between stress and acne. Exp Dermatol. 2004;13 Suppl 4:31-5.

58. Chen W, Tsai SJ, Liao CY, et al. Higher levels of steroidogenic acute regulatory protein and type I 3beta-hydroxysteroiddehydrogenase in the scalp of men with androgenetic alopecia. J Invest Dermatol. 2006;126:2332-5.

59. Hannen RF, Michael AE, Jaulim A, Bhogal R, Burrin JM, Philpott MP. Steroid synthesis by primary human keratinocytes; implications for skin disease. Biochem Biophys Res Commun. 2011;404:62-7.

60. Verdier-Sévrain S, Bonté F, Gilchrest B. Biology of estrogens in skin: implications for skin aging. Exp Dermatol. 2006;15:83-94.

61. Verdier-Sévrain S. Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators. Climacteric. 2007;10:289-97.

62. Affinito P, Palomba S, Sorrentino C, et al. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas. 1999;33:239-47.

63. Callens A, Valliant L, Lecomte P, Berson M, Gall Y, Lorette G. Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of postmenopausal women using non-invasive measurement techniques. Dermatology. 1996;193:289-94.

64. Maheux R, Naud F, Rioux M, et al. A randomized, double-blind, placebocontrolled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol. 1994;170:642-9.

65. Ashcroft G S, Dodsworth J, Van Boxtel E, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med. 1997;3:1209-15.

66. Piérard-Franchimont C, Letawe C, Goffin V, Piérard GE. Skin waterholding capacity and transdermal estrogen therapy for menopause: a pilot study. Maturitas. 1995;22:151-4.

67. Quatresooz P, Piérard-Franchimont C, Gaspard U, Piérard GE. Skin climacteric aging and hormone replacement therapy. J Cosmet Dermatol. 2006;5:3-8.

68. Jee SH, Lee SY, Chiu HC, Chang CC, Chen TJ. Effects of estrogen and estrogen receptor in normal human melanocytes. Biochem Biophys Res Commun. 1994;199:1407-12.

69. Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 1997;109:296-300.

70. Johnson E. Quantitative studies of hair growth in the albino rat. II. The effect of sex hormones. J Endocrinol. 1958;16:351-9.

71. Lynfield YL. Effect of pregnancy on the human hair cycle. J Invest Dermatol. 1960;35:323-7.

72. Speroff L. A clinical understanding of the estrogen receptor. Ann N Y Acad Sci. 2000;900:26-39.

73. Pappas TC, Gametchu B, Watson CS. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. FASEB J. 1995;9:404-10.

74. Rosenfield RL. Hirsutism and the variable response of the pilosebaceous unit to androgen. J Investig Dermatol Symp Proc. 2005;10:205-8.

75. Messenger AG. The control of hair growth: an overview. J Invest Dermatol. 1993;101:4S-9S.

76. Zouboulis CC, Degitz K. Androgen action on human skin – from basic research to clinical significance. Exp Dermatol. 2004;13 Suppl 4:5-10.

77. Fritsch M, Orfanos CE, Zouboulis CC. Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol. 2001;116: 793-800.

78. Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocrine Rev. 2000;21:363-92.

79. Akamatsu H, Zouboulis CC, Orfanos CE. Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Invest Dermatol. 1992;99:509-11.

80. Zouboulis CC, Chen WC, Thornton MJ, Qin K, Rosenfield R. Sexual hormones in human skin. Horm Metab Res. 2007;39:85-95.

81. Rosenfield RL. Hirsutism and the variable response of the pilosebaceous unit to androgen. J Investig Dermatol Symp Proc. 2005;10:205-8.

82. Kao JS, Garg A, Mao-Qiang M, et al. Testosterone perturbs epidermal permeability barrier homeostasis. J Invest Dermatol. 2001;116:443-51.

83. Carmina E, Godwin AJ, Stanczyk FZ, Lippman JS, Lobo RA. The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne. J Endocrinol Invest. 2002;25:765-8.

84. Liu Y, Petreaca M, Martins-Green M. Cell and molecular mechanisms of insulin-induced angiogenesis. J Cell Mol Med. 2009;13:4492-504.

85. Philpott MP, Sanders DA, Kealey T. Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol. 1994;102:857-61.

86. Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul. 2009;43: 157-68.

87. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316:129-39.

88. Poeggeler B, Schulz C, Pappolla MA, et al. Leptin and the skin: a new frontier. Exp Dermatol. 2010;19:12-8.

89. Shirakata Y. Regulation of epidermal keratinocytes by growth factors. J Dermatol Sci. 2010;59:73-80.